TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Applying Telemedicine Technologies in a Novel Model of Organizing and Implementing Comprehensive Cardiac Rehabilitation in Heart Failure Patients - TELEREH-HF
Brief Summary: Applying modern technology of data collecting, monitoring, transmitting and analyzing in order to implement a novel (hybrid) model of comprehensive home-based cardiac rehabilitation in heart failure patients.


Options:
A: Arm Label: Homebased cardiac rehabilitation program; Type: EXPERIMENTAL; Interventions: Device: Homebased cardiac rehabilitation program, Other: Traditional cardiac rehabilitation program | Arm Label: Traditional cardiac rehabilitation; Type: OTHER; Interventions: Other: Traditional cardiac rehabilitation program | Intervention Type: DEVICE; Name: Homebased cardiac rehabilitation program; Assigned to Arm(s): Homebased cardiac rehabilitation program | Intervention Type: OTHER; Name: Traditional cardiac rehabilitation program; Assigned to Arm(s): Homebased cardiac rehabilitation program, Traditional cardiac rehabilitation
B: Arm Label: telerehabilitation group; Type: EXPERIMENTAL; Interventions: Other: home-based telerehabilitation | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: home-based telerehabilitation; Assigned to Arm(s): telerehabilitation group
C: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: Behavioral: Health coaching | Intervention Type: BEHAVIORAL; Name: Health coaching; Assigned to Arm(s): Usual Care
D: Arm Label: Telerehabilitation group; Type: EXPERIMENTAL; Interventions: Other: Telerehabilitation group | Arm Label: Centre - based rehabilitation group; Type: ACTIVE_COMPARATOR; Interventions: Other: Centre - based rehabilitation group | Arm Label: Usual care group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Telerehabilitation group; Assigned to Arm(s): Telerehabilitation group | Intervention Type: OTHER; Name: Centre - based rehabilitation group; Assigned to Arm(s): Centre - based rehabilitation group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Yoga Therapy to Improve Function Among Veterans With Chronic Low Back Pain
Brief Summary: Chronic low back pain (CLBP) is a prevalent condition among VA patients, but many current treatment options have limited effectiveness. In addition to chronic pain, people with chronic low back pain experience increased disability, psychological symptoms such as depression, and reduced health-related quality of life. This randomized controlled study will examine the impact of yoga therapy for improving function and decreasing pain in VA patients with chronic low back pain. Although not every VA patient with chronic low back pain will choose to do yoga, it is an inexpensive treatment modality that is increasingly appealing to many VA patients. If yoga is effective, it could become an additional low-cost option that the VA can offer to better serve Veterans with chronic low back pain.


Options:
A: Intervention Type: PROCEDURE; Name: High intensity motor control exercise (deadlift); Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Low intensity motor control exercise; Assigned to Arm(s): N/A
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: McKenzie method; Type: EXPERIMENTAL; Interventions: Other: McKenzie method | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: OTHER; Name: McKenzie method; Assigned to Arm(s): McKenzie method
C: Arm Label: Yoga; Type: EXPERIMENTAL; Interventions: Behavioral: Yoga Therapy for CLBP | Arm Label: Delayed Treatment Control - Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Yoga Therapy for CLBP; Assigned to Arm(s): Yoga
D: Arm Label: Yoga; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Weekly yoga classes | Arm Label: Physical Therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Individual physical therapy treatment | Arm Label: Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Education | Intervention Type: BEHAVIORAL; Name: Weekly yoga classes; Assigned to Arm(s): Yoga | Intervention Type: BEHAVIORAL; Name: Individual physical therapy treatment; Assigned to Arm(s): Physical Therapy | Intervention Type: BEHAVIORAL; Name: Education; Assigned to Arm(s): Education

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Yoga Therapy to Improve Function Among Veterans With Chronic Low Back Pain
Brief Summary: Chronic low back pain (CLBP) is a prevalent condition among VA patients, but many current treatment options have limited effectiveness. In addition to chronic pain, people with chronic low back pain experience increased disability, psychological symptoms such as depression, and reduced health-related quality of life. This randomized controlled study will examine the impact of yoga therapy for improving function and decreasing pain in VA patients with chronic low back pain. Although not every VA patient with chronic low back pain will choose to do yoga, it is an inexpensive treatment modality that is increasingly appealing to many VA patients. If yoga is effective, it could become an additional low-cost option that the VA can offer to better serve Veterans with chronic low back pain.


Options:
A: Arm Label: kUNDALINI YOGA; Type: EXPERIMENTAL; Interventions: Behavioral: Kundalini yoga | Arm Label: Self care advice to stay active; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self care advice | Arm Label: Exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise | Intervention Type: BEHAVIORAL; Name: Kundalini yoga; Assigned to Arm(s): kUNDALINI YOGA | Intervention Type: BEHAVIORAL; Name: Self care advice; Assigned to Arm(s): Self care advice to stay active | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise
B: Arm Label: Hatha yoga; Type: EXPERIMENTAL; Interventions: Behavioral: hatha yoga | Arm Label: Health education; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: health education | Intervention Type: BEHAVIORAL; Name: hatha yoga; Assigned to Arm(s): Hatha yoga | Intervention Type: BEHAVIORAL; Name: health education; Assigned to Arm(s): Health education
C: Arm Label: Yoga; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Weekly yoga classes | Arm Label: Physical Therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Individual physical therapy treatment | Arm Label: Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Education | Intervention Type: BEHAVIORAL; Name: Weekly yoga classes; Assigned to Arm(s): Yoga | Intervention Type: BEHAVIORAL; Name: Individual physical therapy treatment; Assigned to Arm(s): Physical Therapy | Intervention Type: BEHAVIORAL; Name: Education; Assigned to Arm(s): Education
D: Arm Label: Yoga; Type: EXPERIMENTAL; Interventions: Behavioral: Yoga Therapy for CLBP | Arm Label: Delayed Treatment Control - Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Yoga Therapy for CLBP; Assigned to Arm(s): Yoga

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Comparative Study of Mefloquine and Sulphadoxine-pyrimethamine as Prophylaxis Against Malaria in Pregnant Human Immunodeficiency Virus Positive Patients
Brief Summary: Randomized controlled single blind prospective comparative study.


Options:
A: Intervention Type: DRUG; Name: Monthly sulfadoxine/pyrimethamine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: 2-dose sulfadoxine/pyrimethamine; Assigned to Arm(s): N/A
B: Arm Label: Mefloquine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mefloquine | Arm Label: Sulphadoxine-Pyrimethamine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sulphadoxine-Pyrimethamine | Intervention Type: DRUG; Name: Mefloquine; Assigned to Arm(s): Mefloquine | Intervention Type: DRUG; Name: Sulphadoxine-Pyrimethamine; Assigned to Arm(s): Sulphadoxine-Pyrimethamine
C: Arm Label: Trial 1: IPTp-SP+LLITNs; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sulphadoxine-pyrimethamine | Arm Label: Trial 1: IPTp-MQ (full dose) + LLITNs; Type: EXPERIMENTAL; Interventions: Drug: Mefloquine (full dose) | Arm Label: Trial 1: IPTp-MQ (split dose)+LLITNs; Type: EXPERIMENTAL; Interventions: Drug: Mefloquine (split dose) | Arm Label: Trial 2: CTX+IPTp-Placebo+LLITNs; Type: EXPERIMENTAL; Interventions: Drug: placebo | Arm Label: Trial 2: CTX + IPTp-MQ+ LLITNs; Type: EXPERIMENTAL; Interventions: Drug: mefloquine | Intervention Type: DRUG; Name: Sulphadoxine-pyrimethamine; Assigned to Arm(s): Trial 1: IPTp-SP+LLITNs | Intervention Type: DRUG; Name: Mefloquine (full dose); Assigned to Arm(s): Trial 1: IPTp-MQ (full dose) + LLITNs | Intervention Type: DRUG; Name: Mefloquine (split dose); Assigned to Arm(s): Trial 1: IPTp-MQ (split dose)+LLITNs | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Trial 2: CTX+IPTp-Placebo+LLITNs | Intervention Type: DRUG; Name: mefloquine; Assigned to Arm(s): Trial 2: CTX + IPTp-MQ+ LLITNs
D: Arm Label: IPTp-DP; Type: EXPERIMENTAL; Interventions: Drug: IPTp-DP | Arm Label: ISTp-DP; Type: EXPERIMENTAL; Interventions: Drug: ISTp-DP | Arm Label: IPTp-SP; Type: ACTIVE_COMPARATOR; Interventions: Drug: IPTp-SP | Intervention Type: DRUG; Name: IPTp-SP; Assigned to Arm(s): IPTp-SP | Intervention Type: DRUG; Name: IPTp-DP; Assigned to Arm(s): IPTp-DP | Intervention Type: DRUG; Name: ISTp-DP; Assigned to Arm(s): ISTp-DP

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 2a, Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of MEDI9929 in Adult Subjects With Moderate-to-Severe Atopic Dermatitis
Brief Summary: To assess the efficacy and safety of MEDI9929 in adult subjects with Atopic Dermatitis


Options:
A: Arm Label: Placebo QW; Type: EXPERIMENTAL; Interventions: Drug: Placebo (for Dupilumab), Other: Topical Corticosteroid (TCS) | Arm Label: Dupilumab 300 mg QW; Type: EXPERIMENTAL; Interventions: Drug: Dupilumab, Other: Topical Corticosteroid (TCS) | Intervention Type: DRUG; Name: Dupilumab; Assigned to Arm(s): Dupilumab 300 mg QW | Intervention Type: DRUG; Name: Placebo (for Dupilumab); Assigned to Arm(s): Placebo QW | Intervention Type: OTHER; Name: Topical Corticosteroid (TCS); Assigned to Arm(s): Dupilumab 300 mg QW, Placebo QW
B: Arm Label: Placebo qw; Type: EXPERIMENTAL; Interventions: Drug: Placebo, Other: Background treatment | Arm Label: Dupilumab 200 mg qw; Type: EXPERIMENTAL; Interventions: Drug: Dupilumab, Other: Background treatment | Intervention Type: DRUG; Name: Dupilumab; Assigned to Arm(s): Dupilumab 200 mg qw | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo qw | Intervention Type: OTHER; Name: Background treatment; Assigned to Arm(s): Dupilumab 200 mg qw, Placebo qw
C: Arm Label: MEDI9929 280 mg; Type: EXPERIMENTAL; Interventions: Biological: MEDI9929 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: MEDI9929; Assigned to Arm(s): MEDI9929 280 mg | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Treatment group A; Type: EXPERIMENTAL; Interventions: Drug: Tofacitinib ointment 20mg/g | Arm Label: Treatment B; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo ointment (Vehicle) | Intervention Type: DRUG; Name: Tofacitinib ointment 20mg/g; Assigned to Arm(s): Treatment group A | Intervention Type: DRUG; Name: Placebo ointment (Vehicle); Assigned to Arm(s): Treatment B

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Battlefield Auricular Acupuncture for Control of Post-partum Pain
Brief Summary: We will conduct a randomized controlled trial to determine whether the addition of battlefield auricular acupuncture to standard of care is effective for control of postpartum pain for mothers in the immediate post-partum period. Post-partum patients (DoD beneficiaries) 18 years or older, regardless of gravida/parity, who plan to have a childbirth in a hospital setting will be offered the opportunity to participate in the study through PCM referrals and posted advertisements. After a minimum of 6 hours post-vaginal delivery or 24 hours post caesarean section subjects will be given treatment according to their randomization group. Subjects will be assessed on pain control, overall satisfaction with pain management, and the amount of pharmacological pain medications used. Safety of measures will also be assessed to include infection rates, syncope, vertigo, and hypotension.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Device: Procare abdominal binder | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard of Care | Intervention Type: DEVICE; Name: Procare abdominal binder; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Standard of Care; Assigned to Arm(s): Control
B: Arm Label: Active device; Type: ACTIVE_COMPARATOR; Interventions: Device: Pulsed electromagnetic field device (ActiPatch TM) | Arm Label: Placebo - inactive device; Type: PLACEBO_COMPARATOR; Interventions: Device: Inactive pulsed electromagnetic field device (ActiPatch TM) | Intervention Type: DEVICE; Name: Pulsed electromagnetic field device (ActiPatch TM); Assigned to Arm(s): Active device | Intervention Type: DEVICE; Name: Inactive pulsed electromagnetic field device (ActiPatch TM); Assigned to Arm(s): Placebo - inactive device
C: Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Battlefield Auricular Acupuncture; Type: EXPERIMENTAL; Interventions: Device: Battlefield Auricular Acupuncture | Intervention Type: DEVICE; Name: Battlefield Auricular Acupuncture; Assigned to Arm(s): Battlefield Auricular Acupuncture
D: Arm Label: Binder; Type: EXPERIMENTAL; Interventions: Device: Elastic abdominal binder | Arm Label: No binder; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Elastic abdominal binder; Assigned to Arm(s): Binder

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Battlefield Auricular Acupuncture for Control of Post-partum Pain
Brief Summary: We will conduct a randomized controlled trial to determine whether the addition of battlefield auricular acupuncture to standard of care is effective for control of postpartum pain for mothers in the immediate post-partum period. Post-partum patients (DoD beneficiaries) 18 years or older, regardless of gravida/parity, who plan to have a childbirth in a hospital setting will be offered the opportunity to participate in the study through PCM referrals and posted advertisements. After a minimum of 6 hours post-vaginal delivery or 24 hours post caesarean section subjects will be given treatment according to their randomization group. Subjects will be assessed on pain control, overall satisfaction with pain management, and the amount of pharmacological pain medications used. Safety of measures will also be assessed to include infection rates, syncope, vertigo, and hypotension.


Options:
A: Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Battlefield Auricular Acupuncture; Type: EXPERIMENTAL; Interventions: Device: Battlefield Auricular Acupuncture | Intervention Type: DEVICE; Name: Battlefield Auricular Acupuncture; Assigned to Arm(s): Battlefield Auricular Acupuncture
B: Arm Label: Black tea bag; Type: EXPERIMENTAL; Interventions: Other: Warm water soaked Black Tea Bags | Arm Label: ice packs; Type: ACTIVE_COMPARATOR; Interventions: Other: Frozen perineal pad | Intervention Type: OTHER; Name: Frozen perineal pad; Assigned to Arm(s): ice packs | Intervention Type: OTHER; Name: Warm water soaked Black Tea Bags; Assigned to Arm(s): Black tea bag
C: Arm Label: Binder Arm; Type: EXPERIMENTAL; Interventions: Device: Abdominal binder | Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Abdominal binder; Assigned to Arm(s): Binder Arm
D: Arm Label: Magnesium sulfate; Type: ACTIVE_COMPARATOR; Interventions: Other: Cold pads soaked in Magnesium sulfate solution | Arm Label: Water; Type: SHAM_COMPARATOR; Interventions: Other: Cold pads soaked in water | Intervention Type: OTHER; Name: Cold pads soaked in Magnesium sulfate solution; Assigned to Arm(s): Magnesium sulfate | Intervention Type: OTHER; Name: Cold pads soaked in water; Assigned to Arm(s): Water

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Treatment Effectiveness of Theta Burst Stimulation and Voluntary Trunk Rotation for Patients With Unilateral Neglect in Stroke
Brief Summary: This is a double blinded, randomized control trial with a pretest-posttest control and interventional group design. The assessor is blinded to all assessments and evaluations. All patients with subacute stroke undergo in-patient or out-patient rehabilitation are screened initially by a series of screening test. Suitable patients are assigned randomly to two groups respectively. Group 1 is the experimental group for Transcranial Magnetic Stimulation (TMS) and trunk rotation; Group 2 is the control group with only trunk rotation training and placebo stimulation.


Options:
A: Arm Label: Mirror therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Mirror therapy | Arm Label: Sham mirror; Type: SHAM_COMPARATOR; Interventions: Behavioral: Sham mirror | Arm Label: Covered mirror; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Covered mirror | Intervention Type: BEHAVIORAL; Name: Mirror therapy; Assigned to Arm(s): Mirror therapy | Intervention Type: BEHAVIORAL; Name: Sham mirror; Assigned to Arm(s): Sham mirror | Intervention Type: BEHAVIORAL; Name: Covered mirror; Assigned to Arm(s): Covered mirror
B: Arm Label: Intervention-Control (IC); Type: EXPERIMENTAL; Interventions: Behavioral: Optokinetic stimulation and cueing-based reading therapy (OKS-READ), Behavioral: General neuropsychological treatment | Arm Label: Control-Intervention (CI); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Optokinetic stimulation and cueing-based reading therapy (OKS-READ), Behavioral: General neuropsychological treatment | Intervention Type: BEHAVIORAL; Name: Optokinetic stimulation and cueing-based reading therapy (OKS-READ); Assigned to Arm(s): Control-Intervention (CI), Intervention-Control (IC) | Intervention Type: BEHAVIORAL; Name: General neuropsychological treatment; Assigned to Arm(s): Control-Intervention (CI), Intervention-Control (IC)
C: Arm Label: r-TMS Group; Type: EXPERIMENTAL; Interventions: Device: r-TMS | Arm Label: Sham Group; Type: SHAM_COMPARATOR; Interventions: Device: SHAM | Intervention Type: DEVICE; Name: r-TMS; Assigned to Arm(s): r-TMS Group | Intervention Type: DEVICE; Name: SHAM; Assigned to Arm(s): Sham Group
D: Arm Label: TMS and trunk rotation; Type: EXPERIMENTAL; Interventions: Device: TMS and trunk rotation | Arm Label: Sham TMS and trunk rotation; Type: SHAM_COMPARATOR; Interventions: Device: Sham TMS and trunk rotation | Intervention Type: DEVICE; Name: TMS and trunk rotation; Assigned to Arm(s): TMS and trunk rotation | Intervention Type: DEVICE; Name: Sham TMS and trunk rotation; Assigned to Arm(s): Sham TMS and trunk rotation

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multi-country cOllaborative Project on the rOle of Diet, FOod-related Behaviour, and Obesity in the Prevention of Depression (MoodFOOD)
Brief Summary: The study examines the feasibility and effectiveness of two different nutritional strategies (multi-nutrient supplement and food-related behavioural change) to prevent depression in high-risk overweight European Union citizens. Interventions will last 12 months. Design is a two-by-two factorial randomized controlled prevention trial with four intervention groups:

1. Control group (daily placebo supplements)
2. Multi-nutrient supplementation group (daily multi-nutrient supplement)
3. Food-related behavioural change group (food-related behavioural activation focusing on improving overall diet + placebo supplements)
4. Multi-nutrient supplementation + food-related behavioural activation group (daily multi-nutrient supplement + food-related behavioural activation focusing on improving overall diet).

Follow-up assessment will be conducted at 3, 6, and 12 months for primary and secondary endpoints, and during intervention for compliance, adverse events and mediating variables.Data will first be analyzed according to the intention-to-treat principle, using (mixed model) analysis of covariance with primary and secondary endpoints, testing for the effects of the two nutritional strategies separately as well as combined.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: Multi-nutrient supplement; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Multi-nutrient supplement | Arm Label: Placebo + Behavioral Activation; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral Activation, Other: Placebo | Arm Label: Multi-nutrient + Behavioral Activation; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Multi-nutrient supplement, Behavioral: Behavioral Activation | Intervention Type: DIETARY_SUPPLEMENT; Name: Multi-nutrient supplement; Assigned to Arm(s): Multi-nutrient + Behavioral Activation, Multi-nutrient supplement | Intervention Type: BEHAVIORAL; Name: Behavioral Activation; Assigned to Arm(s): Multi-nutrient + Behavioral Activation, Placebo + Behavioral Activation | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo, Placebo + Behavioral Activation
B: Arm Label: Omega 3 fatty acid (fish oil); Type: ACTIVE_COMPARATOR; Interventions: Drug: OMACOR | Arm Label: dummy pill; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo oral capsule | Intervention Type: DRUG; Name: OMACOR; Assigned to Arm(s): Omega 3 fatty acid (fish oil) | Intervention Type: DRUG; Name: Placebo oral capsule; Assigned to Arm(s): dummy pill
C: Arm Label: 1 Epanova; Type: EXPERIMENTAL; Interventions: Drug: Epanova | Arm Label: 2 Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Epanova | Intervention Type: DRUG; Name: Epanova; Assigned to Arm(s): 1 Epanova, 2 Placebo
D: Intervention Type: DRUG; Name: Triomar™ (omega-3 fatty acids); Assigned to Arm(s): N/A

Answer: A